In this month’s Thorax, North East Thames trainees are once again prominent, with an open access article on guidance for adverse effect monitoring in multidrug-resistant TB (MDR-TB). It highlights the work of the guideline development group, linked to the BTS SAG, whose members include Jess Potter and Will Ricketts. The guideline draws together the best available evidence and expert consensus. It includes recommendations for baseline tests, routine drug and toxicity monitoring guides as well as individual drug monographs for all drugs currently available in the UK to treat TB. These recommendations provide a structure through which healthcare professionals can better manage the complex drug regimens required for the treatment of MDR-TB; minimising the risk of adverse incidents and helping to improve patients’ tolerance, compliance and treatment completion.
You can read the full article here: Potter, J. L., et al. “A UK-based resource to support the monitoring and safe use of anti-TB drugs and second-line treatment of multidrug-resistant TB.” Thorax(2014): thoraxjnl-2014.
Or you can visit the website which will be regularly updated: http://www.tbdrugmonographs.co.uk/